Search - tctmd.com

Displaying 941 - 960 of 1352

Sort: Relevancy | Date

News Daily News

ADAPT-DES Analysis Reopens Debate Over Possible PPI, Clopidogrel Interaction

Caitlin E. Cox

October 28, 2015

News Industry News

Resverlogix Commences Phase 3 Clinical Trial BETonMACE With Apabetalone

October 26, 2015

News Conference News TCT 2015

OCT Feasible for Identifying Factors Related to Stent Thrombosis

October 14, 2015

News Conference News TCT 2015

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

October 13, 2015

News Conference News TCT 2015

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

October 12, 2015

News Daily News

Subestudio ADAPT-DES: Los Cambios de la Práctica podrían disminuir aún más los ya bajos índices de trombosis del stent

Yael L. Maxwell

October 09, 2015

News Daily News

ADAPT-DES Substudy: Practice Changes May Decrease Already Low Stent Thrombosis Rates Even Further

Yael L. Maxwell

October 09, 2015

News Daily News

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Caitlin E. Cox

October 06, 2015

News Daily News

No hay interacción entre el punto de acceso y los efectos del Cangrelor en pacientes con PCI

Caitlin E. Cox

October 06, 2015

News Industry News

Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA

September 29, 2015

Presentation Aortovascular 2015

An Office Guide to the Differential Diagnosis of Ulcers

Presenter: Robert Fridman

September 18, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Daily News

High Restenosis Rate After CTO Bailout Technique Linked to Suboptimal Flow

September 15, 2015

News Daily News

El Alto Índice de Reestenosis Post-Técnica de Rescate de una OTC se asocia a un Flujo Subóptimo

September 15, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Conference News ESC 2015

High-Sensitivity Troponin Assay Use Does Not Appear to Increase Diagnostic Procedures

L.A. McKeown

September 02, 2015

News Conference News ESC 2015

Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes

Yael L. Maxwell

September 01, 2015

News Conference News ESC 2015

TECOS: No Differences in Heart Failure Outcomes When Sitagliptin Added to Usual Care in Diabetics

Yael L. Maxwell

August 31, 2015

News Industry News

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

August 31, 2015

News Conference News ESC 2015

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

L.A. McKeown

August 31, 2015

Advertisement

ADAPT-DES Analysis Reopens Debate Over Possible PPI, Clopidogrel Interaction

Resverlogix Commences Phase 3 Clinical Trial BETonMACE With Apabetalone

OCT Feasible for Identifying Factors Related to Stent Thrombosis

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

Subestudio ADAPT-DES: Los Cambios de la Práctica podrían disminuir aún más los ya bajos índices de trombosis del stent

ADAPT-DES Substudy: Practice Changes May Decrease Already Low Stent Thrombosis Rates Even Further

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

No hay interacción entre el punto de acceso y los efectos del Cangrelor en pacientes con PCI

Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA

An Office Guide to the Differential Diagnosis of Ulcers

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

High Restenosis Rate After CTO Bailout Technique Linked to Suboptimal Flow

El Alto Índice de Reestenosis Post-Técnica de Rescate de una OTC se asocia a un Flujo Subóptimo

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

High-Sensitivity Troponin Assay Use Does Not Appear to Increase Diagnostic Procedures

Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes

TECOS: No Differences in Heart Failure Outcomes When Sitagliptin Added to Usual Care in Diabetics

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content